載入...
CRISPR/Cas Systems to Overcome Challenges in Developing the Next Generation of T Cells for Cancer Therapy
Genetically engineered immune cells with chimeric antigen receptors (CAR) or modified T cell receptors (TCR) have demonstrated their potential as a potent class of new cancer therapeutic strategy. Despite the clinical success of autologous CD19 CAR T cells in hematological malignancies, allogeneic T...
Na minha lista:
| 發表在: | Adv Drug Deliv Rev |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7736063/ https://ncbi.nlm.nih.gov/pubmed/32707148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2020.07.015 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|